Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure
Edward Abraham*, Chris Naum, Venkata Bandi, Daniel Gervich, Stephen F. Lowry, Richard Wunderink, Roland M. Schein, William Macias, Simona Skerjanec, Alex Dmitrienko, Nagy Farid, S. Thomas Forgue, Frank Jiang
Dive into the research topics of 'Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure'. Together they form a unique fingerprint.